Resistance to targeted therapies in breast cancer

We present an in-depth description of resistance to targeted therapies in breast cancer. Targeted therapies discussed here include those used to treat ER+ or Her2+ breast cancers (i.e., Tamoxifen or trastuzumab) or those targeting signaling pathways aberrantly activated in triple negative breast can...

Full description

Saved in:
Bibliographic Details
Other Authors: Prosperi, Jenifer R., (Editor)
Format: eBook
Language: English
Published: Cham, Switzerland : Springer, [2017]
Series: Resistance to targeted anti-cancer therapeutics ; v. 16.
Subjects:
ISBN: 9783319701424
9783319701417
Physical Description: 1 online resource

Cover

Table of contents